• Home
  • CLINICAL SIGNIFICANCE OF PERICARDIAL EFFUSION IN PATIENTS HOSPITALIZED WITH IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS.

CLINICAL SIGNIFICANCE OF PERICARDIAL EFFUSION IN PATIENTS HOSPITALIZED WITH IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS.

Author List
Andrew Hughes, John Power, Olusola A. Orimoloye, Joseph F. Nowatzke, Yuichi Tamura, Mandar Aras, Aarti Asnani, Pierre-Yves Courand, Roberta Florido, Salim Hayek, Vlad Gabriel Zaha, Anita Deswal, Javid Moslehi, Nicolas L. Palaskas
Publication
Journal of the American College of Cardiology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/344526397
Publication Year
2022
Publication Title
Andrew Hughes, John Power, Olusola A. Orimoloye, Joseph F. Nowatzke, Yuichi Tamura, Mandar Aras, Aarti Asnani, Pierre-Yves Courand, Roberta Florido, Salim Hayek, Vlad Gabriel Zaha, Anita Deswal, Javid Moslehi, Nicolas L. Palaskas. CLINICAL SIGNIFICANCE OF PERICARDIAL EFFUSION IN PATIENTS HOSPITALIZED WITH IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS. Journal of the American College of Cardiology. 2022 Mar 1; 79(9):1916.